These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 22299471

  • 1. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W, Wongpoowarak P, Chayakul P, Pattharachayakul S, Tansakul P, Garey KW.
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [Abstract] [Full Text] [Related]

  • 2. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
    Tripodi MF, Durante-Mangoni E, Fortunato R, Utili R, Zarrilli R.
    Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
    Song JY, Kee SY, Hwang IS, Seo YB, Jeong HW, Kim WJ, Cheong HJ.
    J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH, Wang JT, Li SY, Lin YC, Cheng A, Chen YC, Chang SC.
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [Abstract] [Full Text] [Related]

  • 5. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U, Chatsuwan T.
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [Abstract] [Full Text] [Related]

  • 6. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii.
    Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V.
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S95-100. PubMed ID: 22043760
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E, Azap OK, Çolakoğlu Ş, Arslan H.
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
    [Abstract] [Full Text] [Related]

  • 8. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
    Hu Q, Hu Z, Li J, Tian B, Xu H, Li J.
    J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
    [Abstract] [Full Text] [Related]

  • 9. In vitro Evaluation of the Colistin-Carbapenem Combination in Clinical Isolates of A. baumannii Using the Checkerboard, Etest, and Time-Kill Curve Techniques.
    Soudeiha MAH, Dahdouh EA, Azar E, Sarkis DK, Daoud Z.
    Front Cell Infect Microbiol; 2017 Oct; 7():209. PubMed ID: 28596943
    [Abstract] [Full Text] [Related]

  • 10. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
    Choi JY, Park YS, Cho CH, Park YS, Shin SY, Song YG, Yong D, Lee K, Kim JM.
    Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
    Çetinkol Y, Telli M, Altunçekiç Yıldırım A, Çalgın MK.
    Mikrobiyol Bul; 2016 Jul; 50(3):460-5. PubMed ID: 27525401
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii.
    Leelasupasri S, Santimaleeworagun W, Jitwasinkul T.
    J Pathog; 2018 Jul; 2018():3893492. PubMed ID: 29593912
    [Abstract] [Full Text] [Related]

  • 13. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY, Ng LS, Tan E, Huang G.
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [Abstract] [Full Text] [Related]

  • 14. In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
    Karaoglan I, Zer Y, Bosnak VK, Mete AO, Namiduru M.
    J Int Med Res; 2013 Dec; 41(6):1830-7. PubMed ID: 24265334
    [Abstract] [Full Text] [Related]

  • 15. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
    Jeong SH, Bae IK, Park KO, An YJ, Sohn SG, Jang SJ, Sung KH, Yang KS, Lee K, Young D, Lee SH.
    J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
    Ben RJ, Yang MC, Hsueh JC, Shiang JC, Chien ST.
    Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY, Cheong HJ, Lee J, Sung AK, Kim WJ.
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V, Tiengrim S.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [Abstract] [Full Text] [Related]

  • 20. Susceptibility profile of bla OXA-23 and metallo-β-lactamases co-harbouring isolates of carbapenem resistant Acinetobacter baumannii (CRAB) against standard drugs and combinations.
    Sharma S, Banerjee T, Yadav G, Kumar A.
    Front Cell Infect Microbiol; 2022 Mar; 12():1068840. PubMed ID: 36683677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.